Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
DNA flow cytometry of paraffin-embedded tissue.
Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Hedley DW, et al. Cytometry. 1984 Nov;5(6):660. doi: 10.1002/cyto.990050618. Cytometry. 1984. PMID: 6394250 No abstract available.
Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.
Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Hedley DW, et al. J Histochem Cytochem. 1983 Nov;31(11):1333-5. doi: 10.1177/31.11.6619538. J Histochem Cytochem. 1983. PMID: 6619538
Single cell suspensions were then prepared by incubation in 0.5% pepsin, pH 1.5, at 37 degrees C for 30 min. The cells were counted, washed, and stained with 1 microgram/ml 4',6'-diamidino-2-phenylindole for 30 min, and DNA content was measured using an ICP 22 flow cytomet …
Single cell suspensions were then prepared by incubation in 0.5% pepsin, pH 1.5, at 37 degrees C for 30 min. The cells were counted, …
The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: a flow cytometry study using archival material.
Young GA, Hedley DW, Rugg CA, Iland HJ. Young GA, et al. Eur J Cancer Clin Oncol. 1987 Oct;23(10):1497-504. doi: 10.1016/0277-5379(87)90092-7. Eur J Cancer Clin Oncol. 1987. PMID: 3678313
The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases.
Emanuel S, Rugg CA, Gruninger RH, Lin R, Fuentes-Pesquera A, Connolly PJ, Wetter SK, Hollister B, Kruger WW, Napier C, Jolliffe L, Middleton SA. Emanuel S, et al. Cancer Res. 2005 Oct 1;65(19):9038-46. doi: 10.1158/0008-5472.CAN-05-0882. Cancer Res. 2005. PMID: 16204078
Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.
Emanuel SL, Hughes TV, Adams M, Rugg CA, Fuentes-Pesquera A, Connolly PJ, Pandey N, Moreno-Mazza S, Butler J, Borowski V, Middleton SA, Gruninger RH, Story JR, Napier C, Hollister B, Greenberger LM. Emanuel SL, et al. Mol Pharmacol. 2008 Feb;73(2):338-48. doi: 10.1124/mol.107.041236. Epub 2007 Nov 1. Mol Pharmacol. 2008. PMID: 17975007
39 results
Jump to page
Feedback